Imaging Centers in Colorado and Florida, Serving Patients Nationwide
To schedule a consultation: Call 866-722-4806 or icon_emailsmall Send us an email


Stay Connected


CereScan FacebookCereScan YouTubeCereScan LinkedIn


Testimonial


"CereScan's unique functional
brain imaging technology
represents a major advance in
brain analysis."

- Dr. David Perlmutter MD
FACN, ABIHM, Medical
Director of the Perlmutter
Health Center, Author of
"The Better Brain Book".

     

Alzheimer's Disease & Other Dementias

Normal_VS_Alzheimers.jpg


Approximately 5,400,000 people in the U.S. have Alzheimer's disease. With the aging of the baby-boomer market, it is projected that the number of people in the U.S. with Alzheimer’s disease will triple by the year 2050. A recent study found that two-thirds of baby-boomers are personally concerned about getting Alzheimer's disease -- a sign that this condition might replace cancer as this generation's most dreaded disease.

Promising new drug therapies for Alzheimer's disease have been developed (and more are coming) that can slow the progression of the disease. It is now becoming clear that for the new drugs to be most effective it is imperative that the presence of Alzheimer's disease patterns in the brain be found early, BEFORE Alzheimer's symptoms are present. Accordingly, anyone with a history of Alzheimer's in their family should have an intense interest in early detection. Detection prior to symptoms is the key to effective treatment.

Research suggests that CereScan’s brain SPECT imaging can often identify the presence of Alzheimer's disease and can be used as a screening tool several years before the onset of symptoms of this devastating disease. With early detection, current anti-Alzheimer's drugs show promise in their ability to slow the progression of this disorder and have been shown on SPECT images to actually improve blood flow in the affected parts of the brain.

Slowing the progression of Alzheimer's disease gives patients a chance to take advantage of newly developing drug treatments that can possibly further slow progression. It may allow patients to prepare themselves and their families prior to the onset of this insidious disease.

In 2010 the National Institute on Aging and the Alzheimer’s Association recommended expanding the definition of Alzheimer’s disease to include the phases of the disease that occur up to two decades before the onset of symptoms. It also recommended that brain SPECT imaging be employed to detect the presence of mild cognitive impairment, which can be a precursor to Alzheimer’s disease that occurs up to five years before the presence of symptoms.

While Alzheimer’s disease is the most common type of dementia, accounting for between 60-80% of all dementia cases, it is not the only type.  Brain SPECT imaging is able to differentiate between different types of dementia such as vascular dementia or frontotemporal dementia.  This is a very important distinction to make as the treatment and management of each type of dementia is very different.


No matter what your brain based concerns are, our staff and physicians are dedicated to help you feel better. If you have questions, would like to learn more or schedule an appointment, please call us at 866-722-4806 or complete our contact us form.


Denver, CO  •  Naples, FL  •  866-722-4806

© 2012, CereScan, All Rights Reserved.


To schedule a consultation: Call 866-722-4806 or icon_emailsmall Send us an email